In an unprecedented move, the Administrative Court of Rabat issued a judgement obliging the Moroccan government to pay compensation of 250,000 dirhams to a university professor who suffered complications after receiving the AstraZeneca COVID-19 vaccine. The ruling is landmark in the context of health and compensation cases in Morocco, as the causal link between the vaccine and the damages suffered by the plaintiff, who was diagnosed with Guillain-Barré syndrome, a rare disease of the nervous system, was recognised.
The complaint was filed by the professor in June 2022, who reported that she suffered paralysis of the face and lower limbs after receiving the vaccine. Medical expertise indicated that she had Guillain-Barré syndrome, which affected her ability to practice her profession normally, and justified her right to compensation.
AstraZeneca acknowledged in court documents that its vaccine caused side effects such as blood clots and low platelet counts, prompting the company to withdraw doses of the vaccine from the global market.
The ruling is indicative of the growing recognition that states and vaccine manufacturers are responsible for potential side effects, and shows the importance of careful monitoring of the health effects of vaccines and medicines. It also highlights the need to provide fair compensation to individuals who may be adversely affected by public health measures.
This judgement is an important step towards strengthening trust in the health system and sends a clear message that the health and safety of citizens is a top priority, and that there are legal mechanisms that can provide protection and compensation when necessary. It is also a reminder that transparency and accountability are key elements in managing health crises and fostering trust between governments and citizens.
From the website: Fez News